Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05917899
Other study ID # 1736147
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 10, 2023
Est. completion date September 30, 2024

Study information

Verified date August 2023
Source University of California, Davis
Contact Jennifer Rosenthal, MD, MAS
Phone 9167344719
Email rosenthal@ucdavis.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be a pilot test of using telehealth with an interpreter as an additional option for parents with limited English proficiency to join family-centered rounds in the neonatal intensive care unit.


Recruitment information / eligibility

Status Recruiting
Enrollment 36
Est. completion date September 30, 2024
Est. primary completion date September 9, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility We will enroll family units. Family units consist of the hospitalized infant and their eligible parents/guardians. Inclusion Criteria - INFANT: - Infants aged less than 365 days who are admitted to the neonatal intensive care unit - Have at least one eligible parent or guardian (see below for parent eligibility criteria) Exclusion Criteria - INFANT: - Have restrictions placed by child protective services, including visitation restrictions or restricted access to patient information - Infants with a previous neonatal intensive care unit admission (and enrollment) during the trial period - Infants already enrolled in a different trial that includes a virtual family-centered rounds intervention Inclusion Criteria - PARENT: - Aged 18 years or older - Preferred language that is other than English - Have at least one infant enrolled in the trial Exclusion Criteria - PARENT: - Under age 18 years

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Virtual Family-Centered Rounds
The care team will use a computer with a speaker camera, mounted on a stand with wheels to launch telehealth visits using the application ExtendedCare. This platform meets HIPAA security rules and launches from the patient's electronic health record. From within this telehealth visit, a care team member will send a message (via text or email) to the parent(s) that includes a link that can be clicked to open a browser that allows the parent to join the telehealth visit. Parent do not need to download or use an application. The care team will invite the video interpreter to join the visit if a parent is present. Family-centered rounds will then proceed in usual fashion with the care team and [if in attendance] parent(s). Parents can participate in virtual family-centered rounds as much, or as little, as they choose.

Locations

Country Name City State
United States University of California Davis Medical Center Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Family-Centered Rounds Parent Attendance Proportion of the number of weekday round encounters with at least one parent present - either virtually or in-person - divided by the infant's total number of weekday round encounters From date of randomization until the date of disposition from the neonatal intensive care unit for any cause (assessed up to 396 days)
Secondary Patient length of stay Days in the neonatal intensive care unit. Obtained from electronic health record. From date of admission to the neonatal intensive care unit until the date of disposition from the unit for any cause (assessed up to 396 days)
Secondary Breastmilk feeding at discharge Dichotomous outcomes. Include (a) breastmilk feeding initiation, (b) any breastmilk feeding at the time of discharge from the neonatal intensive care unit, and (c) exclusive breastmilk feeding at the time of discharge from the neonatal intensive care unit. Breastmilk feeding includes consuming milk from the birth parent via any delivery method (e.g., bottle, feeding tube, breast). Any breastmilk feeding will be defined as the infant consuming any amount of milk from the birth parent, with or without the addition of formula or fortifier. Exclusive breastmilk feeding will be defined as 100% of base feeding type as milk from the birth parent, with or without a bovine or human fortifier. Obtained from electronic health record (0 days) Date of disposition from the neonatal intensive care unit for any cause (assessed up to 396 days)
Secondary Medical errors and adverse events Include the rates of harmful errors, non-harmful errors, and overall errors (harmful errors plus non-harmful errors). Obtained via review of data from electronic health record and solicited reports. Two neonatologists will independently categorize each event as a harmful error (preventable adverse event), non-harmful error, non-preventable adverse event, or exclusion. Date of disposition from the neonatal intensive care unit for any cause (assessed up to 396 days)
Secondary Patient Experience Unit of measure: mean score; Measure/Tool: Emergency Department CAHPS (Consumer Assessment of Healthcare Providers and Systems) (parent survey, 2 items measuring overall experience). Date of disposition from the neonatal intensive care unit for any cause (assessed up to 396 days)
Secondary Patient Activation Unit of measure: mean score; Measure/Tool: Parent-Patient Activation Measure (P-PAM) (parent survey) Date of disposition from the neonatal intensive care unit for any cause (assessed up to 396 days)
Secondary Parent Quality of Life Unit of measure: mean score. Measure/Tool: PedsQL Family Impact Module (parent survey) Date of disposition from the neonatal intensive care unit for any cause (assessed up to 396 days)
See also
  Status Clinical Trial Phase
Recruiting NCT05590884 - Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age Phase 2
Completed NCT02261857 - 3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea Early Phase 1
Terminated NCT03305562 - Pediatric Hypertension Registry (PHREG)
Completed NCT04506203 - The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool N/A
Completed NCT05095012 - RECOVER Clinical Pathway for Pediatric Concussion N/A
Enrolling by invitation NCT05539456 - Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
Completed NCT04644783 - Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES) N/A
Recruiting NCT02164773 - Addition of Magnesium Sulfate to Caudal to Prevent Postoperative Emergence Agitation. Phase 4
Completed NCT03977948 - Qualitative and Systemic Assessment of a Nurse Intervention an Inpatient Child and His or Her Parents
Completed NCT03358446 - The Optimal Leg Angulation of Femoral Central Catheterization in Pediatrics
Active, not recruiting NCT05087537 - Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve N/A
Active, not recruiting NCT04522778 - Innovative Central Line Securement Device in the Pediatric Population N/A
Completed NCT03966625 - Serological Identification of Celiac Disease in Kids
Completed NCT02625662 - Facioscapulohumeral Dystrophy in Children
Completed NCT03650049 - Food Protein-induced Enterocolitis Syndrome (FPIES) in 14 Children
Enrolling by invitation NCT04435821 - PET/MRI in the Diagnosis of Pediatric Chronic Pain Phase 1
Recruiting NCT04643015 - New Ways of Doing Magnetic Resonance Imaging in Children and Adults
Completed NCT05313295 - Physical Therapy Treatment on Children and Adolescents With Neurological Pathologies N/A
Completed NCT03662113 - Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy N/A
Not yet recruiting NCT05852535 - Spontaneous Evisceration of Infantile Umbilical Hernia